United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments. Could marijuana be the answer?

Treatment 120

Treatment Cannabinoids Blood Pressure THC 120

NORML

MARCH 12, 2020

On March 12th, the House Veterans Affairs Committee (HVAC) passed two separate pieces of legislation pertaining to cannabis policy. The second bill, HR 1647 , known as the Veterans Equal Access Act of 2019, would allow V.A. We must reform our federal cannabis policy.” Presently, V.A.

Marijuana 363

Marijuana Chronic Pain Policy Access 363

NORML

FEBRUARY 13, 2019

Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.

Legislation 237

Legislation Access Chronic Pain Marijuana 237

Cannabis Law Report

AUGUST 20, 2021

The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. Many are finding that despite the treatment being approved, they are being denied access in their area.”. How much longer are we going to have to wait?

Access 105

Access Patients Media Treatment 105

NORML

AUGUST 19, 2019

Currently, public support for legalizing weed nationwide is at an all-time high: 62 percent of Americans favor legalizing the adult use of marijuana, while over 90 percent want access to medical cannabis. If the bill removes cannabis from the Controlled Substances Act, why do new immigration policies need to be clarified by law?

Policy 277

Policy Marijuana Legislation Programs 277

MMJ Recs

FEBRUARY 6, 2024

In the ever-evolving landscape of medical marijuana, accessing cannabis through a dispensary in New Jersey can be both empowering and complex. Familiarize yourself with the dispensary’s rules and policies. Accessing Quality Medical Cannabis Products Quality assurance is paramount when accessing medical cannabis products.

Access 52

Access Dispensary Marijuana Strains 52

Cannabis Law Report

JULY 28, 2021

president and CEO of MJH Life Sciences™, parent company of Cannabis Patient Care ™ “We are thrilled to partner with Americans for Safe Access because we share their passion for education and for helping as many patients as we can.”.

Access 105

Access Patients Education Treatment 105

The Cannigma

MARCH 14, 2023

Laws restricting birth control, abortion, drug use, as well as requirements to receive welfare, drug treatment and even pain medication are developed in a paternalistic nature. The decision by state governments to supersede the views of medical professionals and limit access to medical cannabis is a clear example of paternalism.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

FEBRUARY 12, 2023

Join this FREE, 75-minute online webinar to gain access to insights and learn about ground-breaking treatments to chronic mental health conditions. FREE WEBINAR: Helping to change policy – Influencing the TGA with Professor David Nutt (UK) What we know, what we think, and what we need to research Psychedelic […]

Policy 52

Policy Medicine Events Treatment 52

MMJ Recs

APRIL 19, 2024

In this blog, we’re discussing the past, present, and future of Iowa medical marijuana laws — exploring its history, laws, regulations, patient access, and the evolving role it plays in the state’s healthcare system. These dispensaries play a crucial role in providing patients with safe and legal access to medical cannabis products.

Law 52

Law Marijuana Access History 52

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. PURPOSE : .

Policy 105

Policy Research and Development Chronic Pain Cannabinoids 105

Cannabis Law Report

AUGUST 7, 2022

There is a rapidly growing movement to create safe access to psychedelic medicines. The Microdosing Collective (“Microdosing Collective” or “the Collective”) is a new initiative supporting education around regulatory policy to permit legal microdosing for optimal wellbeing. We seek to change that.”.

Microdosing 52

Microdosing Collective Access Education 52

Cannabis Law Report

MAY 18, 2022

The Home Affairs Committee continues its inquiry into the UK’s drugs policy examining the scientific evidence base underpinning the UK’s approach. The Committee takes evidence from members of the Advisory Council on the Misuse of Drugs, which advises the Government on drugs policy, and other academic experts. Inquiry: Drugs.

Policy 52

Policy Treatment Legislation Access 52

Cannabis Law Report

JUNE 21, 2021

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Access to treatment. Daniel Perkins a b Hugh Brophy a Iain S. Background. Conclusion.

Medicine 59

Medicine Safety Policy Treatment 59

SpeedWeed

MAY 7, 2021

Colorado Governor Jared Polis just signed a bill that will make it easier for students to access medical cannabis while in school. . This legislation will allow students access to life-saving epilepsy treatments and other essential medicines, but still prohibits smokable cannabis on school property. View original article.

Access 52

Access Law Marijuana Policy 52

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

MMJ Recs

APRIL 11, 2024

West Virginia has emerged as a trailblazer in the realm of medical marijuana, implementing a comprehensive program to provide patients with access to this therapeutic treatment option. This program facilitates access to medical cannabis for individuals suffering from qualifying debilitating conditions.

Law 52

Law Programs Patients Conditions 52

NORML

AUGUST 12, 2019

I’m proud to work with NORML to create a more just national marijuana policy. My bill, The MORE Act, is the most comprehensive marijuana reform bill ever introduced, and it’s backed by a broad coalition of civil rights, criminal justice, drug policy, and immigration groups.

Legalization 279

Legalization Marijuana Decriminalization Policy 279

Cannabis Law Report

NOVEMBER 23, 2021

Department of Veterans Affairs (VA) says that while current federal marijuana laws have prevented the department’s physicians from recommending medical cannabis to military veterans, officials are “looking at” the possibility of an internal policy change and have discussed it with the White House. And it was very profound,” McDonough said.

Policy 52

Policy Marijuana Pharmaceutical Treatment 52

Cannabis Law Report

JUNE 12, 2021

Recent shifting attitudes towards the medical use of cannabis has seen legal access pathways established in many jurisdictions in North America, Europe and Australasia. Here we undertake an analysis of this policy issue based on a case study of the introduction of medicinal cannabis in Australia. Background. Conclusion.

Policy 66

Policy Safety Medicine Access 66

Cannabis Law Report

JUNE 14, 2022

Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD. However, there is a growing realization that European health systems may not be prepared for these treatments. More details: Tadeusz Hawrot, PAREA Founder and Policy Lead: tadeusz@parea.science.

Access 52

Access Therapy Clinical Trials Treatment 52

CannaMD

MARCH 19, 2020

As Florida’s leading medical cannabis physicians , CannaMD is committed to working closely with licensed dispensaries to ensure medical cannabis patients stay safe while continuing uninterrupted treatment during the coronavirus (COVID-19) crisis. UPDATE (3/19): MEDICAL MARIJUANA PHYSICIAN APPOINTMENTS. COLUMBIA CARE.

Policy 90

Policy Dispensary Patients Safety 90

MMJ Recs

JANUARY 24, 2024

Michigan, a state at the forefront of progressive healthcare initiatives, has implemented its own Medical Marijuana Program for years now in order to implement alternative treatments into mainstream medical care. The state legalized medical marijuana in 2008, establishing a framework for patients to access cannabis for therapeutic purposes.

Programs 52

Programs Marijuana Access Chronic Pain 52

MMJ Recs

MAY 1, 2024

Through community outreach, social media campaigns, educational seminars, and mental health screenings, the month seeks to empower individuals to seek help when needed, cultivate supportive environments, and advocate for policies that promote mental health equity and access to care.

Marijuana 52

Marijuana Treatment Conditions Chronic Pain 52

MMJ Recs

MARCH 6, 2024

Discover how legalization and regulation have influenced access and usage, and learn about the latest research and medical applications. Legalization and Regulation of Medical Marijuana The journey of legalizing and regulating medical marijuana in the US reflects a nuanced interplay of federal and state policies.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Access to Psychedelic Therapies and Equity in Emerging Psychedelics Industries. Background.

Law 59

Law Policy Research and Development Clinical Trials 59

NORML

MARCH 11, 2020

I introduced the Veterans Equal Access Act, HR 1647 because it is my responsibility as a Member of Congress to ensure that all Americans have access to medical treatment as recommended by their physicians. Today, you can make a difference and show your support for our nation’s veterans and the efficacy of medical cannabis.

Chronic Pain 337

Chronic Pain Marijuana Access Treatment 337

NORML

JULY 23, 2019

“After nearly a century of prohibition, it is clear this policy has been an absolute failure and a national disgrace. The MORE Act is the most comprehensive marijuana reform bill ever introduced in the US Congress and is backed by a broad coalition of civil rights, criminal justice, drug policy, and immigration groups.

Marijuana 255

Marijuana Policy Legislation Programs 255

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Psilocybin Policies Around the Nation Let’s explore where psilocybin is legal, decriminalized, and on the ballot across U.S. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. For example, the Tuskegee Syphilis Study, wherein Black men were deceived regarding their diagnosis and deprived appropriate treatment over the course of decades.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. For more than a year, the Department of Health has fought to keep that information secret.

Data 52

Data Treatment Patients Chronic Pain 52

Veriheal

FEBRUARY 14, 2024

The vote passed 7-0 after a group of senators, first responders, and military members held a press conference regarding the benefits and potential of psilocybin, also known as magic mushrooms , for mental health treatment. The goal is to ensure that psychedelic therapy remains safe, accessible, and affordable to those 21 and older.

Therapy 62

Therapy Legalization Research and Development Treatment 62

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Veriheal

DECEMBER 4, 2023

Let’s take a look at how businesses are parting ways with traditional “cannabis tests” as well as how legal access leads to fair employment opportunities for consumers alike. With the “green wave” gaining momentum, our perceptions and policies concerning cannabis are on the verge of historic change.

Policy 110

Policy Safety Treatment Business 110

MMJ Recs

MARCH 20, 2024

Many dispensaries also offer additional services such as educational resources, patient consultations, and ongoing support programs to address patient concerns and enhance their overall treatment experience. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

NORML

APRIL 30, 2020

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” ” Among pain patients enrolled in medical cannabis access programs, most subjects report eventually decreasing or even eliminating their use of opiates.

Chronic Pain 348

Chronic Pain Clinical Trials Data Patients 348